TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Develops and manufactures IV solutions, vaccines, and other human medical products.

TRILC | IS

Overview

Corporate Details

ISIN(s):
TRETRLC00014 (+1 more)
LEI:
78900003BNEUMO8X3Y93
Country:
Türkiye
Address:
BÜĞDÜZ MAH. ENVER PAŞA CAD. NO: 8 AKYURT / ANKARA, 06750 ANKARA

Description

TURK İLAÇ VE SERUM SANAYİ A.Ş. is a pharmaceutical company engaged in the development, manufacturing, and sale of human medical products. The company's core business revolves around the production of IV Parenteral Solutions (serum), operating a high-capacity manufacturing facility that establishes it as a major supplier. In addition to serum, its portfolio includes a variety of other essential pharmaceuticals such as vaccines, ampoules, vials, and tablets. The company has also established a significant presence in biotechnology with the development of an integrated vaccine production facility.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-19 08:27
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-12-01 09:13
Aversi LLC Yeni iş ilişkisi
Turkish 33.8 KB
2025-11-19 08:47
2025-9 Aylık IMS (IQVIA) resmi verilerinde ürünlerimizin Türkiye Pazarındaki Ku…
Turkish 17.7 KB
2025-11-18 12:36
Emkan Global İle İmzalanan Yetkili Satıcılık Sözleşmesi Hakkında
Turkish 33.8 KB
2025-10-30 16:20
2024 Yılı TSRS Uyumlu Sürdürülebilirlik Raporu
Turkish 1.7 MB
2025-10-30 16:20
2024 Yılı TSRS Uyumlu Sürdürülebilirlik Raporu
Turkish 15.2 KB
2025-10-30 16:19
Sorumluluk Beyanı
Turkish 20.4 KB
2025-10-30 16:19
2025 3 dönem Faaliyet Raporu
Turkish 2.1 MB
2025-10-30 16:19
2025 3 dönem Faaliyet Raporu
English 10.9 KB
2025-10-30 16:18
Financial Report
Turkish 1.7 MB
2025-10-30 16:18
Financial Report
English 2.5 MB
2025-10-28 17:23
Sürdürülebilirlik Komitesi Üye Seçimi
Turkish 17.4 KB
2025-10-07 13:01
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-10-07 12:49
DMO İhale Sonucu Hakkında
English 42.6 KB
2025-09-29 14:13
Finansman Bonosu İtfası Hakkında
English 15.2 KB

Automate Your Workflow. Get a real-time feed of all TURK İLAÇ VE SERUM SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TURK İLAÇ VE SERUM SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TURK İLAÇ VE SERUM SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.